Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Nov 2025 is 0.57% vs -1.04% in Aug 2025
Consolidate Net Profit
QoQ Growth in quarter ended Nov 2025 is 681.82% vs 77.32% in Aug 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Nov 2025 is 20.23% vs -12.71% in Aug 2025
Interest
QoQ Growth in quarter ended Nov 2025 is 1.64% vs 3.39% in Aug 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Nov 2025 has improved from Aug 2025
Compare Quarterly Results Of Pharmarise Holdings Corp. With
Quarterly - Net Sales
QoQ Growth in quarter ended Nov 2025 is 0.57% vs -1.04% in Aug 2025
YoY Growth in quarter ended Nov 2025 is 10.03% vs 13.62% in Nov 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Nov 2025 is 681.82% vs 77.32% in Aug 2025
YoY Growth in quarter ended Nov 2025 is 966.67% vs -92.26% in Nov 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Nov 2025 is 20.23% vs -12.71% in Aug 2025
YoY Growth in quarter ended Nov 2025 is 56.27% vs -39.43% in Nov 2024
Quarterly - Interest
QoQ Growth in quarter ended Nov 2025 is 1.64% vs 3.39% in Aug 2025
YoY Growth in quarter ended Nov 2025 is 63.16% vs 153.33% in Nov 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Nov 2025 has improved from Aug 2025
YoY Growth in quarter ended Nov 2025 has improved from Nov 2024






